← Back to Clinical Trials
Recruiting NCT06609642

NCT06609642 Digital Art and Artificial Intelligence

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06609642
Status Recruiting
Phase
Sponsor Olivier Beauchet
Condition Adults
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-01-22
Primary Completion 2026-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Art application

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-01-22 with a primary completion date of 2026-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims at examining the impact of an immersive and interactive digital application (App) that uses impressionist artworks to promote the mental well-being of both young and older adults. The goal is to study the usability and accessibility of this App, particularly for older adults, who may have sensory impairments and lower digital literacy compared to younger adults. The study is based on the hypothesis that the App, which allows interaction with paintings by Claude Monet and Helen McNicoll, can trigger positive emotions, thereby improving users' well-being. The App uses artificial intelligence to create extensions of the paintings and music based on the sonification of electrophysiological signals captured from plants. The study seeks to answer four research questions: 1. The usage behaviors of young and older adults with the App. 2. The impressions and feedback from users after testing the App. 3. The obstacles and enablers to the App's use. 4. The expectations and needs of users for better use of the App. The study's objectives include analyzing the usage behaviors, impressions, barriers, and needs of both young and older adults. It is a qualitative study based on non-participatory observations and semi-structured interviews with young and older participants who have used the App. The App is based on impressionist artworks, a style known for evoking positive emotions, and aims to promote mental health by harnessing the emotional power of digital art and artificial intelligence.

Eligibility Criteria

1. For adults of any age: 1. Inclusion criteria: * Concordance of sex and gender. * No psychiatric or cognitive disorders. * Ability to understand spoken and written French. * Provide written consent to participate in the study. 2. Exclusion criteria: * Non-binary. * Inability to provide informed consent to participate in the study. * Participation in a concurrent experimental clinical study to avoid interference with our study. * Inability to understand spoken and written French. * Having moderate to severe visual or auditory impairment. 2. Young adults: The inclusion criterion is being aged between 18 and 35 years. 3. Older adults: The inclusion criterion is being aged 60 years or older.

Contact & Investigator

Central Contact

Olivier beauchet, MD

✉ olivier.beauchet@umontreal.ca

📞 5143403540

Frequently Asked Questions

Who can join the NCT06609642 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06609642 currently recruiting?

Yes, NCT06609642 is actively recruiting participants. Contact the research team at olivier.beauchet@umontreal.ca for enrollment information.

Where is the NCT06609642 trial being conducted?

This trial is being conducted at Montreal, Canada.

Who is sponsoring the NCT06609642 clinical trial?

NCT06609642 is sponsored by Olivier Beauchet. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology